| Organism name | Momordica charantia | 
|---|---|
| Genus | Momordica | 
| Family | Cucurbitaceae | 
| Kingdom | Plantae | 
| Linked NCBI taxonomy name | Momordica charantia | 
|---|---|
| Linked NCBI taxonomy ID | 3673 | 
| Linked level | species | 
| Family in NCBI taxonomy | Cucurbitaceae | 
|---|---|
| ID | 3650 | 
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae | 
|---|---|
| ID | 33090 | 
| Plant class | rosids | 
|---|---|
| ID | 71275 | 
| KNApSAcK ID | name | ChEMBL link | CTD link | # of proteins in ChEMBL interaction / related OMIM / related KEGG DISEASE | # of genes in CTD interaction / related diseases | KCF-S cluster | phytochemical cluster | figure | 
|---|---|---|---|---|---|---|---|---|
| C00023770   | Sitosterol / Stigmasta-5,22-dien-3beta-ol / (24R)24-Ethylcholesta-5,22-dien-3beta-ol | CHEMBL221542 CHEMBL1398443 CHEMBL1875388 | 17 / 19 / 12 | No. 53 | No. 11 |   | ||
| C00000911   | Lycopene / all-trans-Lycopene | CHEMBL501174 CHEMBL1984187 | C015329 | 6 / 13 / 13 | 84 / 13 | No. 97 | No. 59 |   | 
| C00048463   | Kuguacin N / (-)-Kuguacin N | No. 119 | No. 51 |   | ||||
| C00048459   | Kuguacin J | No. 119 | No. 51 |   | ||||
| C00034061   | Momordicine I / (+)-Momordicine I | No. 119 | No. 51 |   | ||||
| C00038733   | Charantoside III / (-)-Charantoside III | CHEMBL409789 CHEMBL409790 | No. 202 |   | ||||
| C00038736   | Charantoside VI / (-)-Charantoside VI | CHEMBL266062 CHEMBL400981 | No. 202 |   | ||||
| C00038735   | Charantoside V / (-)-Charantoside V | CHEMBL266062 CHEMBL400981 | No. 202 |   | ||||
| C00038738   | Charantoside VIII / (+)-Charantoside VIII | CHEMBL400959 | No. 202 |   | ||||
| C00038734   | Charantoside IV / (-)-Charantoside IV | CHEMBL409789 CHEMBL409790 | No. 202 |   | ||||
| C00038737   | Charantoside VII / (-)-Charantoside VII | CHEMBL251068 | No. 202 |   | ||||
| C00048468   | Kuguacin S / (-)-Kuguacin S | No. 1475 |   | |||||
| C00048464   | Kuguacin O / (-)-Kuguacin O | No. 1475 |   | |||||
| C00048458   | Kuguacin H / (-)-Kuguacin H | No. 1475 |   | |||||
| C00034003   | Kuguacin D | No. 1475 |   | |||||
| C00034002   | Kuguacin C / (+)-Kuguacin C | No. 1475 |   | |||||
| C00034001   | Kuguacin B / (+)-Kuguacin B | No. 1475 |   | |||||
| C00034000   | Kuguacin A | No. 1475 |   | |||||
| C00038089   | (19R,23E)-5beta,19-Epoxy-19-methoxycucurbita-6,23,25-trien-3beta-ol | CHEMBL249658 | No. 1478 |   | ||||
| C00038088   | (19R,23E)-5beta,19-Epoxy-19,25-dimethoxycucurbita-6,23-dien-3beta-ol | CHEMBL398562 | No. 1478 |   | ||||
| C00048450   | Karavilagenin D / (-)-Karavilagenin D | No. 1478 |   | |||||
| C00029557   | 5beta,19-Epoxy-19-methoxycucurbita-6,23-diene-3beta,25-diol / 19(R)-Methoxy-5beta,19-epoxycucurbita-6,23-dien-3beta,25-diol / 5beta,19-Epoxy-19-methoxycucurbita-6,23(E)-diene-3beta,25-diol | CHEMBL252510 | No. 1478 |   | ||||
| C00048467   | Kuguacin R / (-)-Kuguacin R | No. 1478 |   | |||||
| C00048460   | Kuguacin K / (-)-Kuguacin K | No. 1581 |   | |||||
| C00048466   | Kuguacin Q / (-)-Kuguacin Q | No. 1581 |   | |||||
| C00034004   | Kuguacin E / (+)-Kuguacin E | No. 1581 |   | |||||
| C00048457   | Kuguacin G / (-)-Kuguacin G | No. 1581 |   | |||||
| C00048465   | Kuguacin P / (-)-Kuguacin P | No. 1581 |   | |||||
| C00048456   | Kuguacin F / (-)-Kuguacin F | No. 1581 |   | |||||
| C00048461   | Kuguacin L / (-)-Kuguacin L | No. 3965 |   | |||||
| C00048462   | Kuguacin M / (-)-Kuguacin M | No. 3965 |   | 
| accession | description | class description | KNApSAcK metabolite in interactions | # of diseases (OMIM / KEGG) | 
|---|---|---|---|---|
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00023770 | 1 / 0 | 
| P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00023770 | 0 / 0 | 
| P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00023770 | 2 / 0 | 
| P06746 | DNA polymerase beta | Enzyme | C00023770 | 0 / 0 | 
| P02545 | Prelamin-A/C | Unclassified protein | C00000911 | 11 / 10 | 
| P08047 | Transcription factor Sp1 | Unclassified protein | C00023770 | 0 / 0 | 
| P16473 | Thyrotropin receptor | Glycohormone receptor | C00023770 | 3 / 2 | 
| P08183 | Multidrug resistance protein 1 | drug | C00023770 | 1 / 0 | 
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00023770 | 0 / 1 | 
| P11473 | Vitamin D3 receptor | NR1I1 | C00000911 | 2 / 3 | 
| O75496 | Geminin | Unclassified protein | C00000911 | 0 / 0 | 
| P49841 | Glycogen synthase kinase-3 beta | Gsk | C00023770 | 0 / 0 | 
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00000911 | 0 / 0 | 
| P00734 | Prothrombin | S1A | C00023770 | 4 / 2 | 
| P14679 | Tyrosinase | Oxidoreductase | C00023770 | 4 / 2 | 
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00023770 | 0 / 0 | 
| P03372 | Estrogen receptor | NR3A1 | C00023770 | 1 / 1 | 
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00023770 | 1 / 1 | 
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00023770 | 0 / 1 | 
| P80365 | Corticosteroid 11-beta-dehydrogenase isozyme 2 | Enzyme | C00023770 | 1 / 1 | 
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00000911 | 0 / 0 | 
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00000911 | 0 / 0 | 
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00023770 | 1 / 1 | 
| gene | gene name | gene description | KNApSAcK metabolite in interactions | 
|---|---|---|---|
| 118 | ADD1, ADDA | adducin 1 (alpha) | C00000911 | 
| 177 | AGER, RAGE | advanced glycosylation end product-specific receptor | C00000911 | 
| 196 | AHR, bHLHe76 | aryl hydrocarbon receptor | C00000911 | 
| 207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | C00000911 | 
| 367 | AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM | androgen receptor | C00000911 | 
| 571 | BACH1, BACH-1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 | C00000911 | 
| 8314 | BAP1, HUCEP-13, UCHL2 | BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) (EC:3.4.19.12) | C00000911 | 
| 673 | BRAF, B-RAF1, BRAF1, NS7, RAFB1 | v-raf murine sarcoma viral oncogene homolog B (EC:2.7.11.1) | C00000911 | 
| 841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) | C00000911 | 
| 847 | CAT | catalase (EC:1.11.1.6) | C00000911 | 
| 595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 | C00000911 | 
| 898 | CCNE1, CCNE | cyclin E1 | C00000911 | 
| 983 | CDK1, CDC2, CDC28A, P34CDC2 | cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) | C00000911 | 
| 1019 | CDK4, CMM3, PSK-J3 | cyclin-dependent kinase 4 (EC:2.7.11.22) | C00000911 | 
| 1020 | CDK5, PSSALRE | cyclin-dependent kinase 5 (EC:2.7.11.22) | C00000911 | 
| 1022 | CDK7, CAK1, CDKN7, HCAK, MO15, STK1, p39MO15 | cyclin-dependent kinase 7 (EC:2.7.11.23 2.7.11.22) | C00000911 | 
| 1025 | CDK9, C-2k, CDC2L4, CTK1, PITALRE, TAK | cyclin-dependent kinase 9 (EC:2.7.11.23 2.7.11.22) | C00000911 | 
| 1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | C00000911 | 
| 1113 | CHGA, CGA | chromogranin A (parathyroid secretory protein 1) | C00000911 | 
| 1114 | CHGB, SCG1 | chromogranin B (secretogranin 1) | C00000911 | 
| 23418 | CRB1, LCA8, RP12 | crumbs homolog 1 (Drosophila) | C00000911 | 
| 1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) | C00000911 | 
| 1643 | DDB2, DDBB, UV-DDB2 | damage-specific DNA binding protein 2, 48kDa | C00000911 | 
| 1981 | EIF4G1, EIF-4G1, EIF4F, EIF4G, EIF4GI, P220, PARK18 | eukaryotic translation initiation factor 4 gamma, 1 | C00000911 | 
| 2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 | C00000911 | 
| 2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) | C00000911 | 
| 2176 | FANCC, FA3, FAC, FACC | Fanconi anemia, complementation group C | C00000911 | 
| 2188 | FANCF, FAF | Fanconi anemia, complementation group F | C00000911 | 
| 356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) | C00000911 | 
| 2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog | C00000911 | 
| 2701 | GJA4, CX37 | gap junction protein, alpha 4, 37kDa | C00000911 | 
| 2702 | GJA5, ATFB11, CX40 | gap junction protein, alpha 5, 40kDa | C00000911 | 
| 2879 | GPX4, GPx-4, GSHPx-4, MCSP, PHGPx, snGPx, snPHGPx | glutathione peroxidase 4 (EC:1.11.1.12) | C00000911 | 
| 3146 | HMGB1, HMG1, HMG3, SBP-1 | high mobility group box 1 | C00000911 | 
| 3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 | C00000911 | 
| 3479 | IGF1, IGF-I, IGF1A, IGFI | insulin-like growth factor 1 (somatomedin C) | C00000911 | 
| 3480 | IGF1R, CD221, IGFIR, IGFR, JTK13 | insulin-like growth factor 1 receptor (EC:2.7.10.1) | C00000911 | 
| 3485 | IGFBP2, IBP2, IGF-BP53 | insulin-like growth factor binding protein 2, 36kDa | C00000911 | 
| 3713 | IVL | involucrin | C00000911 | 
| 3716 | JAK1, JAK1A, JAK1B, JTK3 | Janus kinase 1 (EC:2.7.10.2) | C00000911 | 
| 3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene | C00000911 | 
| 3796 | KIF2A, CDCBM3, HK2, KIF2 | kinesin heavy chain member 2A | C00000911 | 
| 3838 | KPNA2, IPOA1, QIP2, RCH1, SRP1alpha | karyopherin alpha 2 (RAG cohort 1, importin alpha 1) | C00000911 | 
| 3949 | LDLR, FH, FHC, LDLCQ2 | low density lipoprotein receptor | C00000911 | 
| 3988 | LIPA, CESD, LAL | lipase A, lysosomal acid, cholesterol esterase (EC:3.1.1.13) | C00000911 | 
| 5604 | MAP2K1, CFC3, MAPKK1, MEK1, MKK1, PRKMK1 | mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) | C00000911 | 
| 5605 | MAP2K2, CFC4, MAPKK2, MEK2, MKK2, PRKMK2 | mitogen-activated protein kinase kinase 2 (EC:2.7.12.2) | C00000911 | 
| 6416 | MAP2K4, JNKK, JNKK1, MAPKK4, MEK4, MKK4, PRKMK4, SAPKK-1, SAPKK1, SEK1, SERK1, SKK1 | mitogen-activated protein kinase kinase 4 (EC:2.7.12.2) | C00000911 | 
| 5608 | MAP2K6, MAPKK6, MEK6, MKK6, PRKMK6, SAPKK-3, SAPKK3 | mitogen-activated protein kinase kinase 6 (EC:2.7.12.2) | C00000911 | 
| 1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) | C00000911 | 
| 5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) | C00000911 | 
| 5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) | C00000911 | 
| 4247 | MGAT2, CDG2A, CDGS2, GLCNACTII, GNT-II, GNT2 | mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase (EC:2.4.1.143) | C00000911 | 
| 100507436 | MICA, MIC-A, PERB11.1 | MHC class I polypeptide-related sequence A | C00000911 | 
| 4292 | MLH1, COCA2, FCC2, HNPCC, HNPCC2, hMLH1 | mutL homolog 1 | C00000911 | 
| 4436 | MSH2, COCA1, FCC1, HNPCC, HNPCC1, LCFS2 | mutS homolog 2 | C00000911 | 
| 2956 | MSH6, GTBP, GTMBP, HNPCC5, HSAP, p160 | mutS homolog 6 | C00000911 | 
| 4842 | NOS1, IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS | nitric oxide synthase 1 (neuronal) (EC:1.14.13.39) | C00000911 | 
| 8021 | NUP214, CAIN, CAN, D9S46E, N214, p250 | nucleoporin 214kDa | C00000911 | 
| 5320 | PLA2G2A, MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2 | phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4) | C00000911 | 
| 5591 | PRKDC, DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, XRCC7, p350 | protein kinase, DNA-activated, catalytic polypeptide (EC:2.7.11.1) | C00000911 | 
| 10111 | RAD50, NBSLD, RAD502, hRad50 | RAD50 homolog (S. cerevisiae) | C00000911 | 
| 8045 | RASSF7, C11orf13, HRAS1, HRC1 | Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 | C00000911 | 
| 5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 | C00000911 | 
| 5962 | RDX, DFNB24 | radixin | C00000911 | 
| 6195 | RPS6KA1, HU-1, MAPKAPK1A, RSK, RSK1 | ribosomal protein S6 kinase, 90kDa, polypeptide 1 (EC:2.7.11.1) | C00000911 | 
| 6197 | RPS6KA3, CLS, HU-3, ISPK-1, MAPKAPK1B, MRX19, RSK, RSK2, S6K-alpha3, p90-RSK2, pp90RSK2 | ribosomal protein S6 kinase, 90kDa, polypeptide 3 (EC:2.7.11.1) | C00000911 | 
| 6241 | RRM2, R2, RR2, RR2M | ribonucleotide reductase M2 (EC:1.17.4.1) | C00000911 | 
| 6401 | SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2 | selectin E | C00000911 | 
| 6414 | SEPP1, SELP, SeP | selenoprotein P, plasma, 1 | C00000911 | 
| 4088 | SMAD3, HSPC193, HsT17436, JV15-2, LDS1C, LDS3, MADH3 | SMAD family member 3 | C00000911 | 
| 8243 | SMC1A, CDLS2, DXS423E, SB1.8, SMC1, SMC1L1, SMC1alpha, SMCB | structural maintenance of chromosomes 1A | C00000911 | 
| 6774 | STAT3, APRF, HIES | signal transducer and activator of transcription 3 (acute-phase response factor) | C00000911 | 
| 7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 | C00000911 | 
| 7980 | TFPI2, PP5, REF1, TFPI-2 | tissue factor pathway inhibitor 2 | C00000911 | 
| 7039 | TGFA, TFGA | transforming growth factor, alpha | C00000911 | 
| 7097 | TLR2, CD282, TIL4 | toll-like receptor 2 | C00000911 | 
| 7099 | TLR4, ARMD10, CD284, TLR-4, TOLL | toll-like receptor 4 | C00000911 | 
| 7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor | C00000911 | 
| 7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 | C00000911 | 
| 7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 | C00000911 | 
| 7415 | VCP, ALS14, IBMPFD, IBMPFD1, TERA, p97 | valosin containing protein (EC:3.6.4.6) | C00000911 | 
| 7485 | WRB, CHD5 | tryptophan rich basic protein | C00000911 | 
| 7697 | ZNF138, pHZ-32 | zinc finger protein 138 | C00000911 | 
| OMIM | preferred title | UniProt | 
|---|---|---|
| #103470 | Albinism, ocular, with sensorineural deafness | P14679 | 
| #203100 | Albinism, oculocutaneous, type ia; oca1a | P14679 | 
| #606952 | Albinism, oculocutaneous, type ib; oca1b | P14679 | 
| #218030 | Apparent mineralocorticoid excess; ame | P80365 | 
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a | P02545 | 
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism | P02545 | 
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 | P02545 | 
| #609535 | Drug metabolism, poor, cyp2c19-related | P33261 | 
| #608902 | Drug metabolism, poor, cyp2d6-related | P10635 | 
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 | P02545 | 
| #615363 | Estrogen resistance; estrr | P03372 | 
| #610140 | Heart-hand syndrome, slovenian type | P02545 | 
| #176670 | Hutchinson-gilford progeria syndrome; hgps | P02545 | 
| #603373 | Hyperthyroidism, familial gestational | P16473 | 
| #609152 | Hyperthyroidism, nonautoimmune | P16473 | 
| #275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 | P16473 | 
| #612244 | Inflammatory bowel disease 13; ibd13 | P08183 | 
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 | P02545 | 
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada | P02545 | 
| #613205 | Muscular dystrophy, congenital, lmna-related | P02545 | 
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b | P02545 | 
| #607948 | Mycobacterium tuberculosis, susceptibility to | P11473 | 
| #614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 | P00734 | 
| #613679 | Prothrombin deficiency, congenital | P00734 | 
| #275210 | Restrictive dermopathy, lethal | P02545 | 
| #604906 | Schizophrenia 9; sczd9 | P49798 | 
| #181500 | Schizophrenia; sczd | P49798 | 
| #601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 | P14679 | 
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 | Q9NUW8 | 
| #601367 | Stroke, ischemic | P00734 | 
| #188050 | Thrombophilia due to thrombin defect; thph1 | P00734 | 
| #277440 | Vitamin d-dependent rickets, type 2a; vddr2a | P11473 | 
| KEGG | name | UniProt | 
|---|---|---|
| H00223 | Inherited thrombophilia | P00734
                            (related) | 
| H01254 | Congenital prothrombin deficiency | P00734
                            (related) | 
| H00264 | Charcot-Marie-Tooth disease (CMT) | P02545
                            (related) | 
| H00294 | Dilated cardiomyopathy (DCM) | P02545
                            (related) | 
| H00420 | Familial partial lipodystrophy (FPL) | P02545
                            (related) | 
| H00563 | Emery-Dreifuss muscular dystrophy | P02545
                            (related) | 
| H00590 | Congenital muscular dystrophies (CMD/MDC) | P02545
                            (related) | 
| H00593 | Limb-girdle muscular dystrophy (LGMD) | P02545
                            (related) | 
| H00601 | Hutchinson-Gilford progeria syndrome | P02545
                            (related) | 
| H00663 | Restrictive dermopathy | P02545
                            (related) | 
| H00665 | Mandibuloacral dysplasia | P02545
                            (related) | 
| H01216 | Left ventricular noncompaction (LVNC) | P02545
                            (related) | 
| H00026 | Endometrial Cancer | P03372
                            (marker) | 
| H00036 | Osteosarcoma | P08684
                            (marker) | 
| H00342 | Tuberculosis | P11473
                            (related) | 
| H00784 | Localized autosomal recessive hypotrichosis | P11473
                            (related) | 
| H01143 | Vitamin D-dependent rickets | P11473
                            (related) | 
| H01205 | Coumarin resistance | P11712
                            (related) | 
| H00168 | Oculocutaneous albinism (OCA) | P14679
                            (related) | 
| H00038 | Malignant melanoma | P14679
                            (marker) | 
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) | P16473
                            (related) | 
| H01269 | Congenital hyperthyroidism | P16473
                            (related) | 
| H01171 | Poor drug metabolism (PM) | P33261
                            (related) | 
| H00259 | Apparent mineralocorticoid excess syndrome | P80365
                            (related) | 
| H00063 | Spinocerebellar ataxia (SCA) | Q9NUW8
                            (related) | 
| MESH or OMIM | name | KNApSAcK metabolite | 
|---|---|---|
| D056486 | Drug-Induced Liver Injury | C00000911 | 
| D006943 | Hyperglycemia | C00000911 | 
| D006965 | Hyperplasia | C00000911 | 
| D007248 | Infertility, Male | C00000911 | 
| D007249 | Inflammation | C00000911 | 
| D007674 | Kidney Diseases | C00000911 | 
| D009369 | Neoplasms | C00000911 | 
| D020258 | Neurotoxicity Syndromes | C00000911 | 
| D011471 | Prostatic Neoplasms | C00000911 | 
| D012878 | Skin Neoplasms | C00000911 | 
| D013733 | Testicular Diseases | C00000911 | 
| D014178 | Translocation, Genetic | C00000911 | 
| D015431 | Weight Loss | C00000911 |